You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API hydroxyzine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing hydroxyzine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc VISTARIL hydroxyzine pamoate 0069-5410 D&C RED NO. 33
Pfizer Laboratories Div Pfizer Inc VISTARIL hydroxyzine pamoate 0069-5410 D&C YELLOW NO. 10
Pfizer Laboratories Div Pfizer Inc VISTARIL hydroxyzine pamoate 0069-5410 FD&C GREEN NO. 3
Pfizer Laboratories Div Pfizer Inc VISTARIL hydroxyzine pamoate 0069-5410 FD&C YELLOW NO. 6
Pfizer Laboratories Div Pfizer Inc VISTARIL hydroxyzine pamoate 0069-5410 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for hydroxyzine

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZYL ALCOHOL

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CORN SYRUP

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 30

Excipient focus: D&C RED NO. 33

Excipient focus: D&C RED NO. 7

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FERROUS OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: PEPPERMINT

Excipient focus: PEPPERMINT OIL

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

hydroxyzine drug variants containing POLYETHYLENE GLYCOL 3350

Company Ingredient NDC
Liberty Pharmaceuticals Inc hydroxyzine hydrochloride 0440-1617
NCS HealthCare of KY Inc dba Vangard Labs hydroxyzine hydrochloride 0615-1525
Major Pharmaceuticals hydroxyzine hydrochloride 0904-0357
Aidarex Pharmaceuticals LLC hydroxyzine hydrochloride 53217-007
State of Florida DOH Central Pharmacy hydroxyzine hydrochloride 53808-0619
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SPEARMINT OIL

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group